...
首页> 外文期刊>Journal of Clinical Microbiology >High-Throughput Next-Generation Sequencing of Polioviruses
【24h】

High-Throughput Next-Generation Sequencing of Polioviruses

机译:脊髓灰质炎病毒的高通量下一代测序

获取原文
           

摘要

The poliovirus (PV) is currently targeted for worldwide eradication and containment. Sanger-based sequencing of the viral protein 1 (VP1) capsid region is currently the standard method for PV surveillance. However, the whole-genome sequence is sometimes needed for higher resolution global surveillance. In this study, we optimized whole-genome sequencing protocols for poliovirus isolates and FTA cards using next-generation sequencing (NGS), aiming for high sequence coverage, efficiency, and throughput. We found that DNase treatment of poliovirus RNA followed by random reverse transcription (RT), amplification, and the use of the Nextera XT DNA library preparation kit produced significantly better results than other preparations. The average viral reads per total reads, a measurement of efficiency, was as high as 84.2% ± 15.6%. PV genomes covering >99 to 100% of the reference length were obtained and validated with Sanger sequencing. A total of 52 PV genomes were generated, multiplexing as many as 64 samples in a single Illumina MiSeq run. This high-throughput, sequence-independent NGS approach facilitated the detection of a diverse range of PVs, especially for those in vaccine-derived polioviruses (VDPV), circulating VDPV, or immunodeficiency-related VDPV. In contrast to results from previous studies on other viruses, our results showed that filtration and nuclease treatment did not discernibly increase the sequencing efficiency of PV isolates. However, DNase treatment after nucleic acid extraction to remove host DNA significantly improved the sequencing results. This NGS method has been successfully implemented to generate PV genomes for molecular epidemiology of the most recent PV isolates. Additionally, the ability to obtain full PV genomes from FTA cards will aid in facilitating global poliovirus surveillance.
机译:脊髓灰质炎病毒(PV)目前的目标是在世界范围内根除和控制。基于Sanger的病毒蛋白1(VP1)衣壳区测序目前是PV监测的标准方法。但是,有时需要全基因组序列才能进行更高分辨率的全局监视。在这项研究中,我们优化了使用下一代测序(NGS)的脊髓灰质炎病毒分离株和FTA卡的全基因组测序方案,旨在实现更高的序列覆盖率,效率和通量。我们发现,DNase治疗脊髓灰质炎病毒RNA,然后进行随机逆转录(RT),扩增,以及使用Nextera XT DNA库制备试剂盒产生的效果明显优于其他制备方法。病毒总效率的平均读数/总读数高达84.2%±15.6%。获得了涵盖参考长度的99%至100%的PV基因组,并通过Sanger测序进行了验证。总共生成了52个PV基因组,在一次Illumina MiSeq运行中多路复用了多达64个样品。这种高通量,不依赖序列的NGS方法有助于检测各种PV,特别是对于疫苗衍生的脊髓灰质炎病毒(VDPV),循环VDPV或免疫缺陷相关VDPV的PV。与以前对其他病毒的研究结果相反,我们的结果表明过滤和核酸酶处理并不能明显提高PV分离株的测序效率。但是,核酸提取后的脱氧核糖核酸酶处理可去除宿主DNA,显着改善了测序结果。此NGS方法已成功实施,以生成PV基因组,用于最新PV分离株的分子流行病学研究。此外,从FTA卡获得完整PV基因组的能力将有助于促进全球脊髓灰质炎病毒的监测。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号